Análisis Argos
HSIC
HSICCara
Henry Schein, Inc. · Healthcare
US$ 86.43
precio al 2026-07-04
Valor justo Argos*
US$ 65–71
vs. su valor justo
33% por encima
Score Argos
62/100
LA RESPUESTA
El mercado le pide crezca 9.5% al año — más de lo que ha demostrado (3.4%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Cotiza 40% por debajo de su valor justo.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Crecimiento estancado o en baja.
VALOR2/6FUTURO2/6PASADO2/6SALUD3/6DIVIDENDO5/6
El Iris de calidad
VALOR2/6FUTURO2/6PASADO2/6SALUD3/6DIVIDENDO5/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance razonable
DividendoDevuelve capital al accionista
Score Argos62de 100Cara
Ingresos4%
US$ 13.2 B
Margen operativo2%
5.7%
Flujo de caja libre14%
US$ 0.6 B
Deuda neta
US$ 3.5 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 9.8B
P/E24.7x
EV/EBITDA12.5x
FCF yield5.8%
ROIC8.6%
Margen operativo5.7%
Crecim. ingresos+4.0%/año
Piotroski F4/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

prnewswire.com · 30 jun
GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide
MIAMI, June 30, 2026 /PRNewswire/ -- GoTu Technology, the nation's leading dental talent marketplace, and Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced a new strategic partnership designed to help dental practices address ongoing staffing challenges and maintain continuity of patient care. Through this collaboration between GoTu and Henry Schein Dental Recruitment Services (a division of Henry Schein Financial Enterprises, LLC, a wholly-owned subsidiary of Henry Schein), dental practices will gain expanded access to GoTu's technology-enabled platform, which connects offices with qualified dental hygienists, dental assistants, and associate dentists for both temporary and permanent staffing needs.
zacks.com · 23 jun
Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
seekingalpha.com · 21 jun
Henry Schein: Smile Because The Upside Isn't Over
Henry Schein remains a dominant global provider in dental and medical practitioner supplies, with strong market shares and ongoing revenue growth. HSIC's Q1 2026 revenue grew 6.3% year-over-year, driven by robust global dental merchandise and equipment demand, particularly in aging and expanding populations. Profitability metrics are mixed, but adjusted net income and EBITDA are rising; management guides for 3–5% revenue growth and mid-single-digit EBITDA growth in 2026.
benzinga.com · 11 jun
This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
247wallst.com · 11 jun
Here Are Thursday’s Best Wall Street Analyst Research Calls: Callaway Golf, Chewy, CME Group, Danaher, General Dynamics, Intel, SpaceX, Rocket Lab, Toast, and More
Pre-Market Stock Futures: Futures are trading higher after a dreadful day on Wall Street, when all the major indices traded lower, and we saw the same pattern that has developed over the last week. The "Buy the Dip" traders come in, briefly get an uptick, and a move higher, and the sellers swarm in to... Here Are Thursday's Best Wall Street Analyst Research Calls: Callaway Golf, Chewy, CME Group, Danaher, General Dynamics, Intel, SpaceX, Rocket Lab, Toast, and More
zacks.com · 4 jun
Why Is Henry Schein (HSIC) Up 4.6% Since Last Earnings Report?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
marketbeat.com · 30 may
Henry Schein Sees Steady Dental Demand, $125M Profit Lift by 2026
Henry Schein NASDAQ: HSIC executives said the company is on track with its 2026 commitments and value-creation plan, while pointing to continued momentum in the U.S. dental market despite broader concerns about consumer confidence.
zacks.com · 28 may
Here's Why Henry Schein (HSIC) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.